KYNTRA BIO, INC. Basic Shares Outstanding (Weighted Average)
KYNTRA BIO, INC. (KYNB) reported Basic Shares Outstanding (Weighted Average) of 4.05 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 4.05M shares, a 0.15% increase year-over-year.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.05M shares, a 0.22% increase year-over-year.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 4.05M shares, a 0.27% increase year-over-year.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.04M shares, a 0.57% increase year-over-year.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 4.04M shares, a 1.02% increase from fiscal 2024.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 4.00M shares, a 95.89% decline from fiscal 2023.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 97.30M shares, a 3.98% increase from fiscal 2022.
- KYNTRA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 93.58M shares, a 1.34% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.05M shares 10-Q · filed 2026-08-13 | 4.05M shares 10-Q · filed 2026-08-13 | 4.05M shares derived: average of 3 quarters · filed 2026-08-13 | 4.05M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 4.05M shares 10-Q · filed 2026-05-12 | 4.05M shares derived: average of 2 quarters · filed 2026-05-12 | 4.05M shares derived: average of 3 quarters · filed 2026-05-12 | 4.04M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 4.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 4.04M shares derived: average of 2 quarters · filed 2026-03-16 | 4.04M shares derived: average of 3 quarters · filed 2026-08-13 | 4.04M shares 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | 4.04M shares 10-Q · filed 2025-11-10 | 4.04M shares derived: average of 2 quarters · filed 2026-08-13 | 4.04M shares 10-Q · filed 2025-11-10 | 4.04M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 4.04M shares 10-Q · filed 2026-08-13 | 4.04M shares 10-Q · filed 2026-08-13 | 4.04M shares derived: average of 3 quarters · filed 2026-08-13 | 4.03M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 4.04M shares 10-Q · filed 2026-05-12 | 100.95M shares 10-Q · filed 2025-05-12 | 4.04M shares derived: average of 2 quarters · filed 2026-05-12 | 4.03M shares derived: average of 3 quarters · filed 2026-05-12 | 4.02M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 4.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 4.03M shares derived: average of 2 quarters · filed 2026-03-16 | 4.02M shares derived: average of 3 quarters · filed 2026-03-16 | 4.00M shares 10-K · filed 2026-03-16 | 100.04M shares 10-K · filed 2025-03-17 | |||
| 2024-09-30 | 4.02M shares 10-Q · filed 2025-11-10 | 100.52M shares 10-Q · filed 2024-11-12 | 4.01M shares derived: average of 2 quarters · filed 2025-11-10 | 3.99M shares 10-Q · filed 2025-11-10 | 99.78M shares 10-Q · filed 2024-11-12 | 51.38M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | 3.99M shares 10-Q · filed 2025-08-11 | 99.83M shares 10-Q · filed 2024-08-06 | 3.98M shares 10-Q · filed 2025-08-11 | 99.41M shares 10-Q · filed 2024-08-06 | 67.16M shares derived: average of 3 quarters · filed 2025-08-11 | 74.93M shares derived: average of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | 98.98M shares 10-Q · filed 2025-05-12 | 98.75M shares derived: average of 2 quarters · filed 2025-05-12 | 98.58M shares derived: average of 3 quarters · filed 2025-05-12 | 98.37M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 98.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 98.38M shares derived: average of 2 quarters · filed 2025-03-17 | 98.16M shares derived: average of 3 quarters · filed 2025-03-17 | 97.30M shares 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | 98.25M shares 10-Q · filed 2024-11-12 | 97.99M shares derived: average of 2 quarters · filed 2024-11-12 | 96.90M shares 10-Q · filed 2024-11-12 | 96.17M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 97.73M shares 10-Q · filed 2024-08-06 | 96.22M shares 10-Q · filed 2024-08-06 | 95.48M shares derived: average of 3 quarters · filed 2024-08-06 | 95.06M shares derived: average of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | 94.69M shares 10-Q · filed 2024-05-06 | 94.36M shares derived: average of 2 quarters · filed 2024-05-06 | 94.16M shares derived: average of 3 quarters · filed 2024-05-06 | 93.99M shares derived: average of 4 quarters · filed 2024-05-06 | ||||
| 2022-12-31 | 94.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 93.90M shares derived: average of 2 quarters · filed 2024-02-26 | 93.76M shares derived: average of 3 quarters · filed 2024-02-26 | 93.58M shares 10-K · filed 2024-02-26 | ||||
| 2022-09-30 | 93.77M shares 10-Q · filed 2023-11-06 | 93.62M shares derived: average of 2 quarters · filed 2023-11-06 | 93.43M shares 10-Q · filed 2023-11-06 | 93.27M shares derived: average of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | 93.47M shares 10-Q · filed 2023-08-07 | 93.26M shares 10-Q · filed 2023-08-07 | 93.10M shares derived: average of 3 quarters · filed 2024-02-26 | 92.98M shares derived: average of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | 93.04M shares 10-Q · filed 2023-05-08 | 92.91M shares derived: average of 2 quarters · filed 2024-02-26 | 92.82M shares derived: average of 3 quarters · filed 2024-02-26 | 92.69M shares derived: average of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | 92.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 92.71M shares derived: average of 2 quarters · filed 2024-02-26 | 92.57M shares derived: average of 3 quarters · filed 2024-02-26 | 92.35M shares 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | 92.64M shares 10-Q · filed 2022-11-07 | 92.46M shares derived: average of 2 quarters · filed 2022-11-07 | 92.21M shares 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | 92.28M shares 10-Q · filed 2022-08-08 | 91.98M shares 10-Q · filed 2022-08-08 | ||||||
| 2020-12-31 | 91.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 90.87M shares derived: average of 2 quarters · filed 2023-02-27 | 90.39M shares derived: average of 3 quarters · filed 2023-02-27 | 89.85M shares 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | 90.56M shares 10-Q · filed 2021-11-09 | 90.00M shares derived: average of 2 quarters · filed 2021-11-09 | 89.41M shares 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | 89.45M shares 10-Q · filed 2020-08-06 | 88.83M shares 10-Q · filed 2020-08-06 | ||||||
| 2019-09-30 | 87.01M shares 10-Q · filed 2020-11-05 | 86.73M shares derived: average of 2 quarters · filed 2020-11-05 | 86.39M shares 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | 86.44M shares 10-Q · filed 2020-08-06 | 86.08M shares 10-Q · filed 2020-08-06 | ||||||
| 2018-09-30 | 84.51M shares 10-Q · filed 2019-11-12 | 84.13M shares derived: average of 2 quarters · filed 2019-11-12 | 83.71M shares 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | 83.75M shares 10-Q · filed 2019-08-08 | 83.31M shares 10-Q · filed 2019-08-08 | ||||||
| 2017-06-30 | 69.64M shares 10-Q · filed 2017-08-07 | 66.85M shares 10-Q · filed 2017-08-07 | ||||||
| 2016-06-30 | 62.58M shares 10-Q · filed 2017-08-07 | 62.38M shares 10-Q · filed 2017-08-07 | ||||||
| 2015-06-30 | 59.80M shares 10-Q · filed 2016-08-08 | 59.50M shares 10-Q · filed 2016-08-08 | ||||||
| 2014-06-30 | 13.35M shares 10-Q · filed 2015-08-13 | 13.28M shares 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |